Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Dick

Showing results (91-100 of 178) with videos related to

Pageof 18
Sort By:
ACS Medicinal Chemistry Letters|May 31, 2021
Amide-Amine Replacement in Indole-2-carboxamides Yields Potent Mycobactericidal Agents with Improved Water SolubilityYu Jia Tan, Ming Li, Gregory Adrian Gunawan, et al.
Microbiology Spectrum|November 15, 2022
<i>In Vitro</i> Profiling of the Synthetic RNA Polymerase Inhibitor MMV688845 against Mycobacterium abscessusLea Mann, Uday S Ganapathy, Rana Abdelaziz, et al.
Journal of Bacteriology|June 16, 2009
Triacylglycerol utilization is required for regrowth of in vitro hypoxic nonreplicating Mycobacterium bovis bacillus Calmette-GuerinKai Leng Low, P S Srinivasa Rao, Guanghou Shui, et al.
Tuberculosis (Edinburgh, Scotland)|June 11, 2021
Reinvestigation of the structure-activity relationships of isoniazidPooja Hegde, Helena I M Boshoff, Yudi Rusman, et al.
Antimicrobial Agents and Chemotherapy|July 26, 2023
ADP-ribosylation-resistant rifabutin analogs show improved bactericidal activity against drug-tolerant <i>M. abscessus</i> in caseum surrogateMin Xie, Uday S Ganapathy, Tian Lan, et al.
Journal of Medicinal Chemistry|June 23, 2026
Rifamycin Structural Modifications Attenuate PXR Binding and CYP3A4 InductionAmir George, Tian Lan, Andrew D Huber, et al.
Antimicrobial Agents and Chemotherapy|April 12, 2017
Rifabutin Is Active against Mycobacterium abscessus ComplexDinah Binte Aziz, Jian Liang Low, Mu-Lu Wu, et al.
Journal of Medicinal Chemistry|October 27, 2021
Functionalized Dioxonaphthoimidazoliums: A Redox Cycling Chemotype with Potent Bactericidal Activities against <i>Mycobacterium tuberculosis</i>Kevin T Fridianto, Ming Li, Kiel Hards, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2017
Towards Selective Mycobacterial ClpP1P2 Inhibitors with Reduced Activity against the Human ProteasomeWilfried Moreira, Sridhar Santhanakrishnan, Grace J Y Ngan, et al.
ACS Infectious Diseases|October 21, 2016
Pyrazinamide Resistance Is Caused by Two Distinct Mechanisms: Prevention of Coenzyme A Depletion and Loss of Virulence Factor SynthesisPooja Gopal, Michelle Yee, Jickky Sarathy, et al.
Pageof 18

Showing results (91-100 of 178) with videos related to

Sort By:
Pageof 18
ACS Medicinal Chemistry Letters|May 31, 2021
Amide-Amine Replacement in Indole-2-carboxamides Yields Potent Mycobactericidal Agents with Improved Water SolubilityYu Jia Tan, Ming Li, Gregory Adrian Gunawan, et al.
Microbiology Spectrum|November 15, 2022
<i>In Vitro</i> Profiling of the Synthetic RNA Polymerase Inhibitor MMV688845 against Mycobacterium abscessusLea Mann, Uday S Ganapathy, Rana Abdelaziz, et al.
Journal of Bacteriology|June 16, 2009
Triacylglycerol utilization is required for regrowth of in vitro hypoxic nonreplicating Mycobacterium bovis bacillus Calmette-GuerinKai Leng Low, P S Srinivasa Rao, Guanghou Shui, et al.
Tuberculosis (Edinburgh, Scotland)|June 11, 2021
Reinvestigation of the structure-activity relationships of isoniazidPooja Hegde, Helena I M Boshoff, Yudi Rusman, et al.
Antimicrobial Agents and Chemotherapy|July 26, 2023
ADP-ribosylation-resistant rifabutin analogs show improved bactericidal activity against drug-tolerant <i>M. abscessus</i> in caseum surrogateMin Xie, Uday S Ganapathy, Tian Lan, et al.
Journal of Medicinal Chemistry|June 23, 2026
Rifamycin Structural Modifications Attenuate PXR Binding and CYP3A4 InductionAmir George, Tian Lan, Andrew D Huber, et al.
Antimicrobial Agents and Chemotherapy|April 12, 2017
Rifabutin Is Active against Mycobacterium abscessus ComplexDinah Binte Aziz, Jian Liang Low, Mu-Lu Wu, et al.
Journal of Medicinal Chemistry|October 27, 2021
Functionalized Dioxonaphthoimidazoliums: A Redox Cycling Chemotype with Potent Bactericidal Activities against <i>Mycobacterium tuberculosis</i>Kevin T Fridianto, Ming Li, Kiel Hards, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2017
Towards Selective Mycobacterial ClpP1P2 Inhibitors with Reduced Activity against the Human ProteasomeWilfried Moreira, Sridhar Santhanakrishnan, Grace J Y Ngan, et al.
ACS Infectious Diseases|October 21, 2016
Pyrazinamide Resistance Is Caused by Two Distinct Mechanisms: Prevention of Coenzyme A Depletion and Loss of Virulence Factor SynthesisPooja Gopal, Michelle Yee, Jickky Sarathy, et al.
Pageof 18